Norihiro Takenouchi

Hirakata, 5731010, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Transferrin Receptor Marks a Foxp3-Low Treg-like Inflammatory T Cell Subset Associated with Disease Severity in HAM/TSP.

Transferrin Receptor Marks a Foxp3-Low Treg-like Inflammatory T Cell Subset Associated with Disease Severity in HAM/TSP.

Journal: Pathogens (Basel, Switzerland)

Published: March 02, 2026

An HTLV-1-Infected Humanized Mouse Model Expressing HLA-A*02:01 Demonstrates Effective CTL-Mediated Suppression of HTLV-1.

An HTLV-1-Infected Humanized Mouse Model Expressing HLA-A*02:01 Demonstrates Effective CTL-Mediated Suppression of HTLV-1.

Journal: Viruses

Published: August 25, 2025

Intra-pol proviral open region of HTLV-1 controls the transcription from both long terminal repeats.

Intra-pol proviral open region of HTLV-1 controls the transcription from both long terminal repeats.

Journal: Retrovirology

Published: May 16, 2025

Zonisamide modulates cholinergic markers and alleviates levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Zonisamide modulates cholinergic markers and alleviates levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Journal: Experimental neurology

Published: April 15, 2025

HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.

HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.

Journal: International journal of molecular sciences

Published: March 25, 2024

Integrative analysis of ATAC-seq and RNA-seq for cells infected by human T-cell leukemia virus type 1.

Integrative analysis of ATAC-seq and RNA-seq for cells infected by human T-cell leukemia virus type 1.

Journal: PLoS computational biology

Published: February 12, 2024

Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.

Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.

Journal: Journal of neurology

Published: November 07, 2023

Quantitative and Morphological Assessment of Computed Tomography-depicted Gynecomastia in Spinal and Bulbar Muscular Atrophy.

Quantitative and Morphological Assessment of Computed Tomography-depicted Gynecomastia in Spinal and Bulbar Muscular Atrophy.

Journal: Academic radiology

Published: December 20, 2021

Zonisamide attenuates the severity of levodopa-induced dyskinesia via modulation of the striatal serotonergic system in a rat model of Parkinson's disease.

Zonisamide attenuates the severity of levodopa-induced dyskinesia via modulation of the striatal serotonergic system in a rat model of Parkinson's disease.

Journal: Neuropharmacology

Published: May 13, 2021

Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.

Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 02, 2021

Efficacy and safety of tacrolimus as long-term monotherapy for myasthenia gravis.

Efficacy and safety of tacrolimus as long-term monotherapy for myasthenia gravis.

Journal: Neuromuscular disorders : NMD

Published: August 20, 2020

Expression of TSLC1 in patients with HAM/TSP.

Expression of TSLC1 in patients with HAM/TSP.

Journal: Journal of neurovirology

Published: August 02, 2019

Showing 1-12 of 22

Last Updated: 09/26/2026